Abstract
Novel 1-benzhydryl piperazine derivatives 7(a-k) and 8(a-i) were synthesised in order to determine their antimicrobial activity and possible structure-activity relationships to improve the efficacy. Their chemical structures were confirmed by 1H NMR, IR and elemental analysis. All the compounds were screened for their in vitro antibacterial activity against Bacillus subtilis, Escherichia coli and Staphylococcus aureus by using Streptomycin as positive control and antifungal activity against Aspergillus niger, Cephalosporium acremonium and Fusarium moniliforme by using Nystatin as positive control. Among the synthesized novel compounds 7h, 7k, 8g, 8h and 8i showed potent antimicrobial activities compared to the standard drugs. The SAR studies reveals that, both linkage and substituents on phenyl ring are responsible for the antimicrobial activity for these class of agents.
Keywords: 1-benzhydryl piperazine derivatives, alkyl halides, aryl halides, isocyanates, minimum inhibitory concentration, antimicrobials
Letters in Drug Design & Discovery
Title: Synthesis and In Vitro Antimicrobial Activity of Medicinally Important Novel N-alkyl, N-aryl and Urea Derivatives of 1-benzhydryl Piperizine: A Structure-Activity Relationship Study
Volume: 6 Issue: 2
Author(s): Channapillekoppal Siddegowda Ananda Kumar, Karunakara Murthy, Marlinganadoddi Panchegowda Sadashiva, Mallappanahally Kambappa Vinaya, Naraganahalli Ramegowda Thimmegowda, Salekoppal Boregowda Benaka Prasad, Siddappa Chandrappa and Kanchugarakoppal Subbegowda Rangappa
Affiliation:
Keywords: 1-benzhydryl piperazine derivatives, alkyl halides, aryl halides, isocyanates, minimum inhibitory concentration, antimicrobials
Abstract: Novel 1-benzhydryl piperazine derivatives 7(a-k) and 8(a-i) were synthesised in order to determine their antimicrobial activity and possible structure-activity relationships to improve the efficacy. Their chemical structures were confirmed by 1H NMR, IR and elemental analysis. All the compounds were screened for their in vitro antibacterial activity against Bacillus subtilis, Escherichia coli and Staphylococcus aureus by using Streptomycin as positive control and antifungal activity against Aspergillus niger, Cephalosporium acremonium and Fusarium moniliforme by using Nystatin as positive control. Among the synthesized novel compounds 7h, 7k, 8g, 8h and 8i showed potent antimicrobial activities compared to the standard drugs. The SAR studies reveals that, both linkage and substituents on phenyl ring are responsible for the antimicrobial activity for these class of agents.
Export Options
About this article
Cite this article as:
Ananda Kumar Siddegowda Channapillekoppal, Murthy Karunakara, Sadashiva Panchegowda Marlinganadoddi, Vinaya Kambappa Mallappanahally, Thimmegowda Ramegowda Naraganahalli, Benaka Prasad Boregowda Salekoppal, Chandrappa Siddappa and Rangappa Subbegowda Kanchugarakoppal, Synthesis and In Vitro Antimicrobial Activity of Medicinally Important Novel N-alkyl, N-aryl and Urea Derivatives of 1-benzhydryl Piperizine: A Structure-Activity Relationship Study, Letters in Drug Design & Discovery 2009; 6 (2) . https://dx.doi.org/10.2174/157018009787582570
DOI https://dx.doi.org/10.2174/157018009787582570 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Histamine as a Potential Adjuvant to Immuno and Radiotherapy for Cancer Treatment: Discovering New Functions for the Oldest Biogenic Amine
Current Immunology Reviews (Discontinued) Pilot Randomized Controlled Study of a Histamine Receptor Inverse Agonist in the Symptomatic Treatment of AD
Current Alzheimer Research The Regulation of Neuroimmune-Endocrine Interactions: Mechanisms,Molecular Pathways Unraveled and the Pivotal Role of Cytokines – A Unsung Putative Bidirectional Interdependence between the Immune and Neuroendocrine Interfaces
Current Immunology Reviews (Discontinued) Oxidative and Nitrosative Stress and Immune-inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
Current Neuropharmacology Proinflammatory Cytokines and Chemokines in Neonatal Brain Damage
Current Pediatric Reviews Cancer and Treatment Modalities
Current Cancer Therapy Reviews Complement System in SLE as a Target for Antibodies
Current Rheumatology Reviews Current Advances in Anti-Influenza Therapy
Current Medicinal Chemistry Astrocyte`s RAGE: More Than Just a Question of Mood
Central Nervous System Agents in Medicinal Chemistry Targeting of Nuclear Factor-κB and Proteasome by Dithiocarbamate Complexes with Metals
Current Pharmaceutical Design The Impact of Uremic Toxins on Alzheimer's Disease
Current Alzheimer Research Thyroid Hormones Crosstalk with Growth Factors: Old Facts and New Hypotheses
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Inflammatory Process as a Determinant Factor for the Degeneration of Substantia Nigra Dopaminergic Neurons: Possible Relevance to the Etiology of Parkinsons Disease
Current Medicinal Chemistry - Central Nervous System Agents Biosafety of Lentiviral Vectors
Current Gene Therapy Anti-Alzheimer Therapeutic Drugs Targeting γ-Secretase
Current Topics in Medicinal Chemistry A New Approach to the Inflammatory/Autoimmune Diseases
Recent Patents on Anti-Infective Drug Discovery Advances in Peptide Pharmaceuticals
Current Pharmaceutical Biotechnology What they are, How they Work and Why they do What they do? The Story of SV40-derived Gene Therapy Vectors and What They Have to Offer
Current Gene Therapy Isoprostanes as Biomarkers and Mediators of Oxidative Injury in Infant and Adult Central Nervous System Diseases
Current Neurovascular Research The Role of CXCR3 in Neurological Diseases
Current Neuropharmacology